Skip to main content

faricimab

Generic: faricimab·Brand: Vabysmo

faricimab: 2 clinical trials tracked.

faricimab evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about faricimab, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy

NCT06790784Registry updated 2026-09-18·Phase 3
Recruiting

Primary endpoint: Visual Acuity Change from Baseline

InterventionalRandomizedsingle426 targetStarted 2025-08Completion 2031-0834 sites · United StatesJaeb Center for Health Research

A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy

NCT05844982Registry updated 2026-08-20·Phase 3
Recruiting

Primary endpoint: Change in visual acuity from baseline

InterventionalRandomizedsingle600 targetStarted 2023-11Completion 2029-1227 sites · United StatesJaeb Center for Health Research